Phase Ib Study of Erlotinib Prior to Surgery in Patients With Head and Neck Cancer

Clinical trial NCT00954226 · COMPLETED

Trial details

NCT number: NCT00954226
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Head and Neck Carcinoma Recurrent Salivary Gland Carcinoma Recurrent Skin Carcinoma Skin Squamous Cell Carcinoma

Start date: 2009-08-05
Primary completion: 2025-04-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.